Literature DB >> 33498789

Synthesis and Biological Activities of Cyclodepsipeptides of Aurilide Family from Marine Origin.

Synthia Michon1, Florine Cavelier1, Xavier J Salom-Roig1.   

Abstract

Aurilides are a class of depsipeptides occurring mainly in marine cyanobacteria. Members of the aurilide family have shown to exhibit strong cytotoxicity against various cancer cell lines. These compounds bear a pentapeptide, a polyketide, and an α-hydroxy ester subunit in their structure. A large number of remarkable studies on aurilides have emerged since 1996. This comprehensive account summarizes the biological activities and total syntheses of natural compounds of the aurilide family as well as their synthetic analogues.

Entities:  

Keywords:  aurilides; depsipeptides; macrocyclization; marine drugs; total synthesis

Mesh:

Substances:

Year:  2021        PMID: 33498789      PMCID: PMC7911808          DOI: 10.3390/md19020055

Source DB:  PubMed          Journal:  Mar Drugs        ISSN: 1660-3397            Impact factor:   5.118


  18 in total

1.  Marine natural product aurilide activates the OPA1-mediated apoptosis by binding to prohibitin.

Authors:  Shin-ichi Sato; Asako Murata; Tsubasa Orihara; Takashi Shirakawa; Kiyotake Suenaga; Hideo Kigoshi; Motonari Uesugi
Journal:  Chem Biol       Date:  2011-01-28

2.  Prohibitin(g) cancer: aurilide and killing by Opa1-dependent cristae remodeling.

Authors:  Martina Semenzato; Sara Cogliati; Luca Scorrano
Journal:  Chem Biol       Date:  2011-01-28

3.  Kulokekahilide-2, a cytotoxic depsipeptide from a cephalaspidean mollusk Philinopsis speciosa.

Authors:  Yoichi Nakao; Wesley Y Yoshida; Yuuki Takada; Junji Kimura; Liu Yang; Susan L Mooberry; Paul J Scheuer
Journal:  J Nat Prod       Date:  2004-08       Impact factor: 4.050

4.  Total synthesis and cytotoxicity studies of a cyclic depsipeptide with proposed structure of palau'amide.

Authors:  Bin Zou; Kai Long; Dawei Ma
Journal:  Org Lett       Date:  2005-09-15       Impact factor: 6.005

5.  Structure-Activity Relationship Study on Odoamide: Insights into the Bioactivities of Aurilide-Family Hybrid Peptide-Polyketides.

Authors:  Masato Kaneda; Shinsaku Kawaguchi; Nobutaka Fujii; Hiroaki Ohno; Shinya Oishi
Journal:  ACS Med Chem Lett       Date:  2018-03-05       Impact factor: 4.345

6.  Lagunamide C, a cytotoxic cyclodepsipeptide from the marine cyanobacterium Lyngbya majuscula.

Authors:  Ashootosh Tripathi; Jonathan Puddick; Michele R Prinsep; Matthias Rottmann; Kok Ping Chan; David Yu-Kai Chen; Lik Tong Tan
Journal:  Phytochemistry       Date:  2011-09-06       Impact factor: 4.072

7.  Total synthesis of odoamide, a novel cyclic depsipeptide, from an Okinawan marine cyanobacterium.

Authors:  Masato Kaneda; Kosuke Sueyoshi; Toshiaki Teruya; Hiroaki Ohno; Nobutaka Fujii; Shinya Oishi
Journal:  Org Biomol Chem       Date:  2016-09-26       Impact factor: 3.876

8.  Diverse synthesis of marine cyclic depsipeptide lagunamide A and its analogues.

Authors:  Wei Huang; Rong-Guo Ren; Han-Qing Dong; Bang-Guo Wei; Guo-Qiang Lin
Journal:  J Org Chem       Date:  2013-10-23       Impact factor: 4.354

9.  The structure of Palau'amide, a potent cytotoxin from a species of the marine cyanobacterium Lyngbya.

Authors:  Philip G Williams; Wesley Y Yoshida; Michael K Quon; Richard E Moore; Valerie J Paul
Journal:  J Nat Prod       Date:  2003-12       Impact factor: 4.050

10.  Structure Determinants of Lagunamide A for Anticancer Activity and Its Molecular Mechanism of Mitochondrial Apoptosis.

Authors:  Xiaoxing Huang; Wei Huang; Li Li; Xihuan Sun; Siyang Song; Qingyan Xu; Lianru Zhang; Bang-Guo Wei; Xianming Deng
Journal:  Mol Pharm       Date:  2016-10-17       Impact factor: 4.939

View more
  1 in total

Review 1.  Marine Cyanobacteria as Sources of Lead Anticancer Compounds: A Review of Families of Metabolites with Cytotoxic, Antiproliferative, and Antineoplastic Effects.

Authors:  Benjamín Robles-Bañuelos; Lorena María Durán-Riveroll; Edgar Rangel-López; Hugo Isidro Pérez-López; Leticia González-Maya
Journal:  Molecules       Date:  2022-07-27       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.